BioSig Technologies Inc's (NASDAQ:BSGM) Natasha Drapeau tells Proactive that physicians have completed 1,000 patient cases with its technology across nine installation sites.
Drapeau says it is currently conducting patient cases in nine medical centers across the country. Texas Cardiac Arrhythmia Institute at St. David’s Medical Center in Austin, Mayo Clinic Florida Campus — BioSig’s first commercial customers — and the University of Pennsylvania count among the most prominent technology users with over 600 patient cases conducted to date.